[October 20, 2014]
Since its first appearance in 2009, the World Health Summit (WHS) brings together opinion leaders from academia, politics, civil society, and the private sector to take responsibility in all health related challenges
Nathalie Strub-Wourgaft, DNDi Medical Director, spoke at a workshop on ethics in research and business.
Ethics in Research and Business
Date: October 20, 2014
Frédéric Dardel, Dean, Université Descartes Paris, France
François Bompart, Vice President, Deputy Head and Medical Director Access to Medicines, Sanofi, France
|Bernd Carsten Stahl, Director, Center for Computing and Social Responsibility, School of Computer Science and Informatics, De Montfort University, United Kingdom
Innovation in ICT and Ethical Issues for the Health Industry
|Isidoros Karatzas, Head of Ethics Sector, DG Research and Innovation, European Commission, Belgium
Legal and Ethical Dimensions of Responsible Innovation in the EU
|Nathalie Strub-Wourgaft, Medical Director, DNDi, Switzerland
Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative “Pre-Review” Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis
|Paul Chew, Senior Vice, President Chief Medical Officer, Sanofi, France
Bioethics and Corporate Social Responsibility: What is at Stake for Private Companies?